BLISSGVS.BO
BLISSGVS.BO
INE416D01022
BLISS GVS PHARMA LTD.
Loading chart...

Company Profile

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Related stocks

MOREPENLAB.NS
MOREPENLAB.NS • India
MOREPEN LAB. LTD
129.55 INR
733.49M USD 1Y +170.4%
SPARC.NS
SPARC.NS • India
SUN PHARMA ADV.RES.CO.LTD
185.6 INR
622.35M USD 1Y +46.6%
IOLCP.BO
IOLCP.BO • India
IOL CHEMICALS & PHARMACEUTICAL
200.85 INR
609.17M USD 1Y +100.2%
AKUMS.NS
AKUMS.NS • India
AKUMS DRUGS AND PHARMA L
751.85 INR
1.19B USD 1Y +78.6%
4887.T
4887.T • Japan
SAWAI GROUP HOLDINGS CO LTD
1,629.5 JPY
1.19B USD 1Y -18.6%
6185.HK
6185.HK • China
CANSINOBIO
35.02 HKD
1.1B USD 1Y -28.6%
AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
50.1% p.a.
Max Drawdown (5Y)
-41.3%
Sharpe Ratio (5Y)
0.80
Beta Factor
1.22
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 51.2 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (56.9%) is noticeably higher than the 5Y average (50.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.9% in the extended horizon.
ende